TY - JOUR T1 - COVID-19 Bimodal Clinical and Pathological Phenotypes JF - medRxiv DO - 10.1101/2021.09.03.21262841 SP - 2021.09.03.21262841 AU - Sabrina S Batah AU - Maíra N Benatti AU - Li Siyuan AU - Wagner M Telini AU - Jamile Barbosa AU - Marcelo B Menezes AU - Tales R Nadai AU - Keyla S G Sá AU - Chirag M. Vaswani AU - Sahil Gupta AU - Dario S Zamboni AU - Danilo T Wada AU - Rodrigo T Calado AU - Renê D R Oliveira AU - Paulo Louzada-Junior AU - Maria Auxiliadora-Martins AU - Flávio P Veras AU - Larissa D Cunha AU - Thiago M Cunha AU - Rodrigo Luppino-Assad AU - Marcelo L Balancin AU - Sirlei S Morais AU - Ronaldo B Martins AU - Eurico Arruda AU - Fernando Chahud AU - Marcel Koenigkam-Santos AU - Andrea A Cetlin AU - Fernando Q Cunha AU - Claudia dos Santos AU - Vera L Capelozzi AU - Junya Fukuoka AU - Rosane Duarte-Achcar AU - Alexandre T Fabro Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/09/14/2021.09.03.21262841.abstract N2 - Background Patients with coronavirus disease-2019 (COVID-19) present varying clinical complications. Different viral load and host response related to genetic and immune background are probably the reasons for these differences. We aimed to sought clinical and pathological correlation that justifies the different clinical outcomes among COVID-19 autopsies cases.Methods Minimally invasive autopsy was performed on forty-seven confirmed COVID-19 patients from May-July, 2020. Electronic medical record of all patients was collected and a comprehensive histopathological evaluation was performed. Immunohistochemistry, immunofluorescence, special stain, western blotting and post-mortem real-time reverse transcriptase polymerase chain reaction on fresh lung tissue were performed.Results We show that 5/47 (10,6%) patients present a progressive decline in oxygenation index for acute respiratory distress syndrome (PaO2/FiO2 ratio), low compliance levels, interstitial fibrosis, high α-SMA+ cells/protein expression, high collagens I/III deposition and NETs(P<0.05), named as fibrotic phenotype (N=5). Conversely, 10/47 (21,2%) patients demonstrated progressive increase in PaO2/FiO2 ratio, high pulmonary compliance levels, preserved elastic framework, increase thrombus formation and high platelets and D-dimer levels at admission (P<0.05), named as thrombotic phenotype. While 32/47 (68,1%) had a mixed phenotypes between both ones.Conclusions We believe that categorization of patients based on these two phenotypes can be used to develop prognostic tools and potential therapies since the PaO2/FiO2 ratio variation and D-dimer levels correlate with the underlying fibrotic or thrombotic pathologic process, respectively; which may indicate possible clinical outcome of the patient.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Sao Paulo Research Foundation (FAPESP) [2019/01517-3, 2019/19591-5 and 2020/13370-4].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The procedures followed in the study were approved by the National Ethics Committee, Brazil (CAAE: 2475220.5.0000.5440). The written informed consent was waived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request. Source data are provided with this paper. ER -